Jan Smith
Company: Revolution Medicines
Job title: Chief Scientific Officer
Seminars:
Targeting Beyond G12C in RAS-Addicted Cancers: Opportunities Using RAS(ON) Tri-Complex Inhibitors 12:45 pm
day: Day One Track B AM
Company: Revolution Medicines
Job title: Chief Scientific Officer
day: Day One Track B AM